New drug cocktail aims to tame tough leukemia
NCT ID NCT07392814
First seen Feb 06, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This early-phase study tests adding tocilizumab to standard chemotherapy (venetoclax and azacitidine) for adults with acute myeloid leukemia who cannot handle strong treatment. The goal is to find the safest dose and see if the combination helps control the disease. Only 12 participants will be enrolled at one hospital.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, ACUTE MYELOID (AML) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU of Nantes
Nantes, 44000, France
Conditions
Explore the condition pages connected to this study.